Astronauts who embarked on spaceflights lasting longer than six months experienced a decrease in the functionality of NK cells, which play an important role of the immune system by killing cancerous cells and preventing viruses from reactivating.

Visualizing your significant other may be just as effective as having them in the room with you when it comes to managing the body's cardiovascular response to stress.

The UA is partnering with Kerafast to license a reagent that offers the opportunity for the development of a rapid, highly sensitive diagnostic test for the zoonotic disease.

A team of UA researchers led by biomedical engineer Nan-kuei Chen is using a $2.1 million grant to improve MRI technologies for challenging patient populations.

Andrew Fuglevand is using artificial intelligence to stimulate multiple muscles to elicit natural movement in ways previous methods have been unable to do.

A clinical trial at the UA Cancer Center in Phoenix will be the first to use immunotherapy as a primary treatment option for liver cancer.

UA scientists hope they have made progress toward a next-generation drug that may slow tumor growth and boost radiation’s effectiveness in patients with the deadly brain cancer.

Researchers at the UA Cancer Center hope early-phase clinical trials will lead to new treatment options for melanoma patients with BRAF or MEK mutations.

Dr. Michael Kruer has received the first federally funded grant to research genetic causes of a condition that affects 1 in 250 children.

A $2 million grant from the U.S. Department of Defense will support research on 3D-printed scaffolds that support the repair of devastating bone injuries.